Renata (DHA:RENATA) FCF Margin % : -22.89% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Renata FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Renata's Free Cash Flow for the three months ended in Dec. 2023 was BDT-2,111 Mil. Renata's Revenue for the three months ended in Dec. 2023 was BDT9,225 Mil. Therefore, Renata's FCF Margin % for the quarter that ended in Dec. 2023 was -22.89%.

As of today, Renata's current FCF Yield % is -2.87%.

The historical rank and industry rank for Renata's FCF Margin % or its related term are showing as below:

DHA:RENATA' s FCF Margin % Range Over the Past 10 Years
Min: -22.82 Med: 6 Max: 14.25
Current: -7.23

During the past 13 years, the highest FCF Margin % of Renata was 14.25%. The lowest was -22.82%. And the median was 6.00%.

DHA:RENATA's FCF Margin % is ranked worse than
63.84% of 1026 companies
in the Drug Manufacturers industry
Industry Median: -0.68 vs DHA:RENATA: -7.23

Renata FCF Margin % Historical Data

The historical data trend for Renata's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renata FCF Margin % Chart

Renata Annual Data

Trend

Dec13

Dec14

Dec15

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Margin %

Get a 7-Day Free Trial

10.44

8.52

-0.34

-22.82

-11.18

Renata Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-36.29	-11.84	5.38	0.72	-22.89

Competitive Comparison of Renata's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Renata's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Renata's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Renata's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Renata's FCF Margin % falls into.

Renata FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Renata's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-3684.707	/	32970.756
	=	-11.18 %

Renata's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-2111.217	/	9224.87
	=	-22.89 %

Renata FCF Margin % Related Terms

Thank you for viewing the detailed overview of Renata's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Renata (DHA:RENATA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renata PLC (DHA:RENATA) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

Plot Number 1, Milk Vita Road, Section-7, GPO Box No. 303, Mirpur, Dhaka, BGD, 1216

Website

https://www.renata-ltd.com

Renata Ltd is a Bangladesh based pharmaceutical company. It is engaged in the manufacturing, marketing, and distribution of Human Pharmaceuticals, Animal Health Medicines, Nutritionals, and Vaccines. It manufactures various pharmaceutical products including Beconex Zi Syrup, Cabolin Tablet, Flontin Tablet, Ivana Tablet, and others. Some of the animal health products offered by the company are Doxivet Powder, Fevenil Injection, Diadin Bolus, Renamet Tablet, and others. The company operates in Bangladesh and sells its products locally and internationally.

Renata (DHA:RENATA) Headlines

No Headlines